Skip to main content

LEADING SARCOMA EXPERT, DR. EARL W. BRIEN, M.D. '86, JOINS CYTRX BOARD OF DIRECTORS

CytRx Corporation, a biopharmaceutical research and development company specializing in oncology, has announced the appointment of Earl Warren Brien, M.D., a noted sarcoma surgeon, industry consultant, and private healthcare investor, to its Board of Directors.

"Dr. Brien is a healthcare leader with clinical and strategic experience at the highest level," said Steven A. Kriegsman, CytRx's Chairman and CEO. "As one of the world's leading orthopedic surgeons, Dr. Brien has performed thousands of sarcoma-related surgeries over the course of his career.  He brings a wealth of knowledge to CytRx through his first-hand experience in treating patients with soft tissue sarcomas coupled with years of providing strategic counsel to both biotech and medical device companies. On behalf of the entire Board and management team, I welcome him and look forward to his contributions as we advance aldoxorubicin toward a New Drug Application (NDA) filing for the treatment of soft tissue sarcomas."

Dr. Brien commented, "My background and deep familiarity with sarcoma, both as a surgeon and a collaborator with treating sarcoma physicians, enables me to bring a unique, real world perspective to CytRx and I am delighted to join its Board of Directors and to work closely with this world-class scientific and entrepreneurial team. With positive Phase 3 results now in hand, I believe aldoxorubicin represents a major step forward for sarcoma patients and I look forward to making contributions that will assist in bringing this promising new treatment candidate to patients suffering with this rare, complex and difficult-to-treat cancer."

Dr. Brien is a board certified orthopedic and sarcoma surgeon who currently serves as a Professor of Orthopedic Surgery and Surgical Director of the Sarcoma Service at Cedars-Sinai Medical Center in Los Angeles, California.  He completed fellowships at the Memorial Sloan-Kettering Cancer Center in Orthopedic Oncology and at the Hospital for Special Surgery at Cornell University. Over his more than twenty-year career, Dr. Brien has received numerous research grants, given over 140 scientific presentations, and been published in numerous peer-reviewed journals and books.

Powered by Firespring